Idrees Mian

1.6k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Idrees Mian is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Idrees Mian has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Idrees Mian's work include Occupational and environmental lung diseases (9 papers), Cancer Research and Treatments (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Idrees Mian is often cited by papers focused on Occupational and environmental lung diseases (9 papers), Cancer Research and Treatments (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Idrees Mian collaborates with scholars based in United States, Switzerland and Denmark. Idrees Mian's co-authors include Yezaz A. Ghouri, Boris Blechacz, Raffit Hassan, Betsy Morrow, Anish Thomas, Seth M. Steinberg, Azam Ghafoor, Manjistha Sengupta, Jun S. Wei and Javed Khan and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer.

In The Last Decade

Idrees Mian

15 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis

2017 573 citations Idrees Mian et al. Journal of Carcinogenesis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Idrees Mian United States	11	455	244	222	212	210	15	1.1k
Mairene Coto‐Llerena Switzerland	16	608 1.3×	279 1.1×	351 1.6×	436 2.1×	243 1.2×	39	1.3k
Karen Man‐Fong Sze Hong Kong	17	635 1.4×	199 0.8×	115 0.5×	309 1.5×	268 1.3×	32	1.1k
Rong‐Yaun Shyu Taiwan	20	491 1.1×	143 0.6×	156 0.7×	128 0.6×	173 0.8×	40	1.1k
Carolina Armengol Spain	18	486 1.1×	181 0.7×	70 0.3×	140 0.7×	172 0.8×	32	940
Xiaoqing Jiang China	18	663 1.5×	176 0.7×	94 0.4×	484 2.3×	239 1.1×	33	1.1k
Joanna H.M. Tong Hong Kong	15	931 2.0×	97 0.4×	139 0.6×	363 1.7×	270 1.3×	22	1.3k
Benjamin Ruf United States	14	280 0.6×	146 0.6×	144 0.6×	146 0.7×	343 1.6×	29	869
Xi‐Dai Long China	22	793 1.7×	101 0.4×	107 0.5×	480 2.3×	190 0.9×	65	1.2k
Zhiping Ruan China	21	721 1.6×	77 0.3×	212 1.0×	321 1.5×	408 1.9×	58	1.2k
Ming-hua Zhu China	21	833 1.8×	110 0.5×	83 0.4×	461 2.2×	289 1.4×	50	1.2k

Countries citing papers authored by Idrees Mian

Since Specialization

Citations

This map shows the geographic impact of Idrees Mian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idrees Mian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idrees Mian more than expected).

Fields of papers citing papers by Idrees Mian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Idrees Mian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idrees Mian. The network helps show where Idrees Mian may publish in the future.

Co-authorship network of co-authors of Idrees Mian

This figure shows the co-authorship network connecting the top 25 collaborators of Idrees Mian. A scholar is included among the top collaborators of Idrees Mian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Idrees Mian. Idrees Mian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nair, Nishanth Ulhas, Qun Jiang, Jun S. Wei, et al.. (2023). Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. Cell Reports Medicine. 4(2). 100938–100938. 11 indexed citations

Ghafoor, Azam, Idrees Mian, Betsy Morrow, et al.. (2021). Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene. JTO Clinical and Research Reports. 2(10). 100231–100231. 33 indexed citations

Jiang, Qun, Azam Ghafoor, Idrees Mian, et al.. (2020). Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models. Science Translational Medicine. 12(550). 35 indexed citations

Mian, Idrees, Emerson Padiernos, Raffit Hassan, & Azam Ghafoor. (2020). Orbital metastases from malignant mesothelioma. The Lancet Oncology. 21(2). e117–e117. 1 indexed citations

Hassan, Raffit, Christine Alewine, Idrees Mian, et al.. (2020). Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin. Cancer. 126(22). 4936–4947. 40 indexed citations

Hassan, Raffit, Idrees Mian, Emerson Padiernos, et al.. (2020). Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.. Journal of Clinical Oncology. 38(15_suppl). 9054–9054. 12 indexed citations

Mian, Idrees, Zied Abdullaev, Betsy Morrow, et al.. (2019). Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma. Journal of Thoracic Oncology. 15(3). 457–461. 23 indexed citations

Jiang, Qun, Azam Ghafoor, Idrees Mian, et al.. (2019). MA12.11 Anti-Tumor Efficacy of Mesothelin Targeted Immunotoxin LMB-100 Plus Pembrolizumab in Mesothelioma Patients and Mouse Models. Journal of Thoracic Oncology. 14(10). S299–S300. 1 indexed citations

Hassan, Raffit, Betsy Morrow, Tom Walsh, et al.. (2018). Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genes.. Journal of Clinical Oncology. 36(15_suppl). 8504–8504. 4 indexed citations

10.

Mian, Idrees, et al.. (2017). Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. Journal of Carcinogenesis. 16(1). 1–1. 573 indexed citations breakdown →

11.

Mian, Idrees, Ming Yang, Hui Zhao, et al.. (2016). Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab.. Journal of Clinical Oncology. 34(15_suppl). 3047–3047. 22 indexed citations

12.

Mian, Idrees, Denái R. Milton, Nina Shah, et al.. (2016). Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. Cancer. 122(24). 3831–3837. 18 indexed citations

13.

Blechacz, Boris, Yezaz A. Ghouri, & Idrees Mian. (2015). Cancer review: Cholangiocarcinoma. Journal of Carcinogenesis. 14(1). 1–1. 118 indexed citations

14.

Ghouri, Yezaz A., et al.. (2015). Hydropic Gallbladder in Three Patients with Poorly Controlled Diabetes Mellitus: What Constitutes Optimal Management?. JOP, journal of the pancreas. 16(3). 290–294. 2 indexed citations

15.

Mian, Idrees. (1997). Comparative sequence analysis of ribonucleases HII, III, II PH and D. Nucleic Acids Research. 25(16). 3187–3195. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact